Apptly Health Technologies Corp. (CSE: APPT) (OTCQB: ESVNF) announced on September 2, 2026, that its common shares have been approved for trading on the OTCQB Venture Market in the United States under the symbol "ESVNF," effective the same date. The company simultaneously confirmed its shares are eligible for electronic clearing and settlement through the Depository Trust Company (DTC). The dual development is intended to improve liquidity and visibility among US investors for the operator of the UberDoc direct-pay healthcare marketplace, while the company's CSE listing under "APPT" remains unchanged.

Key Points

  • Apptly Health Technologies Corp. (CSE: APPT) (OTCQB: ESVNF)
  • Common shares approved for OTCQB Venture Market trading under symbol "ESVNF," effective September 2, 2026
  • Shares confirmed as DTC eligible, enabling electronic clearing and settlement for US investors; company continues to trade on the CSE under "APPT"
  • Investors may be watching whether the expanded US market access translates into increased trading volumes and a broader shareholder base

Apptly's OTCQB Listing Opens Direct US Investor Access to ESVNF Shares

The OTCQB Venture Market is a US-regulated marketplace for early-stage and developing companies, and Apptly's approval provides American investors with a domestic avenue to trade its shares without the friction of cross-border transactions. The company stated that both the OTCQB listing and DTC eligibility are expected to improve liquidity and visibility among US investors as it seeks to broaden its shareholder base. DTC eligibility is significant because it allows US brokers to electronically clear and settle trades, removing a common operational barrier for retail and institutional investors alike.

UberDoc Marketplace Underpins Apptly's US Growth Narrative

Apptly operates UberDoc, a direct-pay healthcare marketplace that connects patients with board-certified specialists through transparent, upfront pricing, eliminating traditional referral requirements and insurance barriers. According to the announcement, the platform features more than 5,000 specialist physicians and clinicians across more than 55 specialties in all 50 US states. The company's founder and Chief Executive Officer, Dr. Paula M. Muto, stated in the release that the OTCQB approval removes a barrier to entry at an important point in the company's growth and gives US investors the chance to participate in direct-pay healthcare.

Liquidity and Shareholder Base Expansion the Stated Goals of the Dual Market Strategy

By maintaining its CSE listing while adding OTCQB access, Apptly is pursuing a dual-market strategy aimed at attracting both Canadian and US investors. The company's release describes improved liquidity and expanded investor visibility as the primary anticipated benefits. The immediate share price impact was not clear from available public information. Investors may be watching trading volumes on both exchanges in the periods ahead to assess whether the OTCQB listing achieves the shareholder base broadening the company describes as a strategic objective.